濮阳东方医院看阳痿口碑很好放心-【濮阳东方医院】,濮阳东方医院,濮阳东方妇科医院做人流口碑非常好,濮阳东方妇科医院电话咨询,濮阳东方医院妇科技术非常专业,濮阳东方医院男科治阳痿收费不高,濮阳东方医院看男科病技术很权威,濮阳东方医院治早泄怎么样

SAN DIEGO (CNS) - Authorities reached out to the public Wednesday for help in identifying a motorist involved in a Linda Vista-area hit-and-run that left three people injured three weeks ago.The fugitive driver lost control of a black Honda while trying to make a right-hand turn from eastbound Linda Vista Road right turn onto Goshen Street at high speed shortly before 11 p.m. Oct. 12, according to San Diego police.The sedan skidded across the roadway, crashed broadside into a car stopped for a stop sign at the intersection and pushed the vehicle into a fire hydrant. Following the wreck, the driver of the damaged Honda steered back onto Linda Vista Road and fled to the east.The victims, two men and a woman in their 20s, were treated for various injuries, including concussions, police said.No description of the driver has been released.Anyone with information about the case is asked to call San Diego County Crime Stoppers at 888-580-8477 or contact the agency online at sdcrimestoppers.org. Tipsters may remain anonymous and could be eligible for a reward of up to ,000. 1092
SAN DIEGO (CNS) - A San Diego molecular diagnostic company announced Thursday it has been awarded a contract from the U.S. Department of Health and Human Services to fund development of its coronavirus diagnostic test, which the company says would provide results in about 30 minutes.Mesa Biotech Inc. will receive both 1,330 in funding and "technical expertise" from the HHS's Biomedical Advanced Research and Development Authority -- or BARDA -- to complete developmental work needed to obtain Emergency Use Authorization from the U.S. Food and Drug Administration.The FDA's emergency authorizations fast-track unapproved medical products for use during a public health emergency.Mesa says its Accula SARS-CoV-2 test utilizes throat swabs to detect SARS-CoV-2, the virus that causes COVID-19."As the coronavirus situation escalates and the demand for testing far exceeds capacity, we are encouraged by the support of HHS in the development of our Accula SARS-CoV-2 Test," said Hong Cai, Mesa Biotech's co- founder and CEO."Our test, which was developed to enable rapid responses to global pandemics, will significantly compress the sample-to-result timeframe with a laboratory-quality test at the point-of-care," Cai said. "This accelerated response will enable health care providers to rapidly screen, isolate, treat or dismiss potential carriers of the virus."In the past week, three companies with local laboratories received emergency approval from the FDA to supply COVID-19 detection tests, including Hologic Inc. and Quidel Corp. in San Diego, and Thermo Fisher Scientific Inc. in Carlsbad.Mesa Biotech's diagnostic test is one of four to receive funding from BARDA, according to the agency."Diagnostics are a critical need in the overall strategy to fight this newest global public health threat," BARDA Director Rick A. Bright said. "We need increased testing capacity in the U.S. to rapidly identify, isolate and treat those infected with COVID-19 in order to limit transmission of the virus, and we need those tests as close to the patients as possible."Currently, no FDA-approved diagnostics, vaccines or treatments for COVID-19 are available. 2168

SAN DIEGO (CNS) - A man was struck and killed Sunday morning by a hit- and-run motorist in an SUV, in the Sherman Heights community of San Diego, a police officer said.The vehicle was going eastbound in the No. 1 lane in the 1800 block of Market Street, where a pedestrian was standing in the street or crossing Market Street at 1:55 a.m., said San Diego police officer Robert Heims.The vehicle struck the pedestrian and dragged him for approximately 100 feet eastbound on Market Street, Heims said.The motorist fled the location eastbound on Market Street and the pedestrian was pronounced dead at the scene.The vehicle was possibly a silver GMC Envoy or similar model, with front end damage.Anyone with any information regarding the death was asked to call Crime Stoppers at 888-580-8477. 798
SAN DIEGO (CNS) - Coroner's officials today said that a worker who fell 60 feet to his death while setting up a stage for the first weekend of the Coachella Valley Music and Arts Festival in Indio was a 49-year-old San Diego man.The worker was identified as Christopher Griffin, according to the Riverside County Coroner's Office. The Riverside County Fire Department reported receiving a call of someone falling from a roof at 9:26 a.m. Saturday near the intersection of Monroe Street and Avenue 50.The venue for the festival, the Empire Polo Club, is located on the southwest corner of that intersection. Griffin was pronounced dead at the scene, fire officials said.In a written statement Saturday, the festival's production company, Goldenvoice, confirmed the death."Today, Goldenvoice lost a colleague, a friend, a family member. Our friend fell while working on a festival stage. It is with heavy hearts and tremendous difficulty that we confirm his passing. He has been with our team for twenty years in the desert and was doing what he loved. He was a hard- working and loving person that cared deeply about his team. As our lead rigger, he was responsible for the countless incredible shows that have been put on at the festival. We will miss him dearly,'' the company said.The Indio Police Department was investigating the death. According to the entertainment website TMZ, Griffin was climbing the stage scaffolding to install rigging equipment and was not using a safety harness when he fell. 1512
SAN DIEGO (CNS) - An infectious disease expert for Scripps Health reminded San Diegans Tuesday to get influenza shots early this season to avoid potentially overloading the region's medical system during the COVID-19 pandemic."If you normally get the flu shot each year, then now is the time to make arrangements for your vaccination, and if you rarely or never get a shot, then this is the year to start doing it," said Dr. Siu Ming Geary, an internal medicine physician and vice president of primary care for Scripps Clinic Medical Group.Symptoms for typical seasonal influenza, such as fever, coughing, headache and fatigue, are similar to those for COVID-19, the illness caused by the coronavirus, and both viruses attack the respiratory system. It remains unclear how the two viruses might interact or affect overall sickness when infecting the same person."We don't yet know how bad this year's flu season will be, but it is possible to get both the coronavirus and the flu at the same time," Geary said. "Both can result in severe illness and complications, including hospitalization and death. While there is not a readily available vaccine for coronavirus, we do know that being vaccinated for influenza is the best thing you can do to protect yourself from getting the flu."Last year, 105 people died from the flu in San Diego County, while the virus killed as many as 62,000 nationwide. The 2017-18 season was even worse, with 343 deaths in San Diego County and 79,000 nationwide."While some experts may disagree about the optimum timing to receive the flu shot, most, including those at the Centers for Disease Control and Prevention, recommend getting the shot by the end of October," Geary said. "As for this year, with the coronavirus pandemic still in full swing, it's not too early to get the flu shot right now."While flu vaccine supplies have sometimes run thin in the past, that shouldn't be the case this year, Geary said. Pharmaceutical companies have produced up to 198 million doses of the vaccine for the U.S. market, a record-setting amount that tops last year's supply by 20 million.The CDC recommends annual influenza vaccination for everyone 6 months or older, especially those who are at high risk for complications from the flu -- including people 65 years and older, children under the age of 2, pregnant women and people with chronic conditions such as asthma, diabetes, heart disease, neurological conditions, blood disorders, weakened immune systems and morbid obesity.This year's vaccine is designed to cover the four strains expected to be the most common in circulation during the 2020-21 influenza season: Influenza A (H1N1), influenza A (H3N2), influenza B (Victoria) and influenza B (Yamagata). 2743
来源:资阳报